CGTX vs DAL · $120.8M cap vs P/E 12, rev $35.61B
Cognition Therapeutics Inc (CGTX) versus Delta Air Lines Inc (DAL) — a side-by-side from cached financials, not a winner call.
Cognition Therapeutics Inc (CGTX) is a biotechnology company listed on US.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
CGTX does not have a complete income-statement cache yet.
Latest reported DAL revenue for 2026-06-30 was $35.61B. Net income was $1.31B. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
CGTX currently screens at market cap $120.8M. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Not investment advice. Open the CGTX and DAL stock pages for the full models.
Not investment advice.